Back
Pelthos Therapeutics, Inc. 10K Form
Sell
13
PTHS
Pelthos Therapeutics, Inc.
Last Price:
$27.15
Seasonality Move:
225.3%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PTHS News And Ratings
See the #1 stock for the next 7 days that we like better than PTHS
PTHS Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-15.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $18.85 |
| Price / Book: | 0.3 |
Profitability
| EPS (TTM): | -14.19210 |
|---|---|
| Net Income (TTM): | $-23.3M |
| Gross Margin: | $0 |
| Return on Equity: | -241.95% |
| Return on Assets: | -87.78% |
Pelthos Therapeutics, Inc. Earnings Forecast
Key Pelthos Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 5 years have been positive in 1 years.
Pelthos Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PTHS |
| Website: | pelthos.com |
Debt
| Debt-to-Equity Ratio: | 0.06 |
|---|---|
| Current Ratio: | 1.98 |
| Quick Ratio: | 0.9 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PTHS Technical Analysis vs Fundamental Analysis
Sell
13
Pelthos Therapeutics, Inc. (PTHS)
is a Sell
Is Pelthos Therapeutics, Inc. a Buy or a Sell?
-
Pelthos Therapeutics, Inc. stock is rated a SellThe current Pelthos Therapeutics, Inc. [PTHS] share price is $26.57. The Score for PTHS is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.